Edward Buckingham, MD
Facial Plastic Surgery · Austin, TXNPI 1467434142
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $13,512 of the $15,006 with a category attached, or 90.0%. AbbVie accounts for 96.1% of it on its own, with 5 other manufacturers making up the rest. Among facial plastic surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 108 payments — averaging $138.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$14K
- Revance Therapeutics, Inc.$187
- Galderma Laboratories, L.p.$181
- Hologic Sales And Service, LLC$104
- Baxter Healthcare$91
- Medline Industries LP$16
What the payments were for
- Speaking & faculty fees$13,51290%
- Food & beverage$1,49410%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 93 | $14,426 |
| Revance Therapeutics, Inc. | 3 | $187 |
| Galderma Laboratories, L.p. | 7 | $181 |
| Hologic Sales And Service, LLC | 1 | $104 |
| Baxter Healthcare | 3 | $91 |
| Medline Industries LP | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$429
- DAXXIFY$135
- BOTOX COSMETIC$119
- CoolSeal Generator$104
How this compares
$15,006 in reported general payments places this provider in the 90th percentile of 42 facial plastic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 52 | $290 |
| ValacyclovirValacyclovir Hcl | 29 | $277 |
| Ondansetron OdtOndansetron | 47 | $224 |
| Dexamethasone | 62 | $177 |
| Tranexamic Acid | 48 | $136 |
| Doxycycline Monohydrate | 22 | $136 |
| Cephalexin | 52 | $108 |
| Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen | 17 | $70 |
Paid to pharmacies, not to this prescriber.
Other facial plastic surgery in Austin
- David NolenAustin$3K
- Jeremy BarrAustin$793
- David TellerAustin$133
- Jose BarreraSan Antonio$120K
- Eli GordinDallas$52K
- Ifeolumipo SofolaThe Woodlands$49K
- Vu HoPlano$33K
- Tang HoHouston$4K
- Kent DavisHouston$4K
- Regina RodmanGalveston$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.